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Abstract
Background: Nationwide surveys have shown that the prevalence of diabetes rates in Malaysia have almost
doubled in the past ten years; yet diabetes control remains poor and insulin therapy is underutilized. This study
aimed to explore healthcare professionals’ views on barriers to starting insulin therapy in people with type 2
diabetes.
Methods: Healthcare professionals consisting of general practitioners (n=11), family medicine specialists (n=10),
medical officers (n=8), government policy makers (n=4), diabetes educators (n=3) and endocrinologists (n=2)
were interviewed. A semi-structured topic guide was used to guide the interviews by trained facilitators. The
interviews were transcribed verbatim and analysed using a thematic analysis approach.
Results: Insulin initiation was found to be affected by patient, healthcare professional and system factors. Patients’
barriers include culture-specific barriers such as the religious purity of insulin, preferred use of complementary
medication and perceived lethality of insulin therapy. Healthcare professionals’ barriers include negative attitudes
towards insulin therapy and the ‘legacy effect’ of old insulin guidelines; whilst system barriers highlight the lack of
resources, language and communication challenges.
Conclusions: Tackling the issue of insulin initiation should not only happen during clinical consultations. It requires
health education to emphasise the progressive nature of diabetes and the eventuality of insulin therapy at early
stage of the illness. Healthcare professionals should be trained how to initiate insulin and communicate effectively
with patients from various cultural and religious backgrounds.
Background
The incidence of diabetes is increasing globally [1,2] par-
ticularly in the Asia Pacific region [3]. Currently, Malaysia
has the highest prevalence rate of diabetes (11.6%) in the
Western Pacific region [4] and it is the 10
th highest in the
world [2]. This alarming rise in the prevalence of diabetes
is has been attributed to increasing affluence, rapid
urbanization, and a diet rich in carbohydrates [4]. In
addition, Malaysia having an upper-middle-income econ-
omy, high treatment costs of diabetes and its associated
complications have imposed a substantial healthcare bur-
den to her already stretched health system [5]. As such,
in 2010, the Ministry of Health of Malaysia has included
diabetes as a priority area in the National Strategic Plan-
ning for Non-Communicable Diseases [6].
Malaysia has a dual-sector healthcare system com-
prising government-subsidised public healthcare facil-
ities and more expensive, private healthcare clinics and
hospitals [7]. Patients are free to choose where they re-
ceive treatment, but patients prefer to seek treatment
in government facilities as treatment costs are lower
there compared to private clinics. Out-of-pocket ex-
penditure was 40.5% of total healthcare expenditure in
2009 [8]. In primary care, the private sector comprises
mostly solo general practice clinics [9] whilst public
primary care consists of government health clinics and
university-based primary care clinics. There are about
five times more private primary care clinics compared
to the public sector in Malaysia [10]. Primary care
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ondary care referrals [10].
The quality of diabetes care in private primary care
clinics is doctor-dependent as clinics are mostly solo
practices employing nursing aides with little formal
training [9,10]. In the public sector, the quality of care
also varies, often better in the urban health clinics and
university-based primary care clinics due to the presence
of family medicine specialists and multidisciplinary dia-
betes teams [9]. Clinics in the public sector provide more
comprehensive diabetes services but have a high patient
load compared to private clinics [10].
The majority of patients with diabetes are managed
in the government facilities; the rest are treated by pri-
vate general practitioners or take complementary and
alternative medications [4]. Despite the established risk
of microvascular complications associated with hyper-
glycaemia [11], diabetes control remains poor in the
Malaysian primary care setting. Eighty percent (80%) of
the patients in the private [12], and 69.1% in the public
setting, failed to achieve an HbA1c level of less than
7.0% [13]. One main reason for poor control is the lack
of timely treatment intensification such as initiation of
insulin therapy [14]. In a community based national
health survey, only 7.2% of Malaysian patients with type
2 diabetes used insulin, either alone or as combination
therapy [4], compared to 36% in the United States [15].
The Malaysian clinical practice guideline (CPG) for type
2 diabetes was last updated in 2009 and insulin therapy
was stated as part of the treatment algorithm [16]. How-
ever, there was no mention of how insulin initiation could
be implemented in the local healthcare setting. Recognis-
ing this gap, a practical guide for insulin therapy was
developed in 2010 and a section was dedicated specifically
to addressing patients’ barriers to insulin initiation [17].
However, the recommendations are based on Western
data and experts’ opinions. There is little research on what
barriers the multi-ethnic Malaysian patients with type 2
diabetes face when deciding to initiate insulin. Studies
from other countries have described various barriers to in-
sulin initiation such as needle phobia, low self-efficacy and
feelings of personal failure [18,19]. It is reported that up to
a third of patients are unwilling to start insulin therapy
when advised to do so [18,19].
Insulin can only be prescribed by doctors in Malaysia
and can be initiated at either primary or secondary care
settings. Nurse educators play an important role in the
public sector as doctors would refer patients to the
nurses for education and instruction after prescribing in-
sulin. On the other hand, private doctors often seek help
from diabetes educators, who are sponsored by pharma-
ceutical companies or non-governmental organizations.
Malaysia’s multi-cultural society consists of three main
ethnic races (Malays, Chinese and Indians) and many
other smaller ethnic groups [20], which may influence
how both healthcare professionals and patients view in-
sulin therapy. This study, therefore, aimed to identify
barriers to insulin initiation from the healthcare profes-
sionals’ perspective. It is only through understanding the
barriers to insulin initiation that healthcare professionals
can address patients’ concerns and help them make deci-
sions about starting insulin. This study was part of a lar-
ger three-year complex intervention study which aimed
to develop a local patient decision aid for insulin
initiation.
Methods
Design
Qualitative, semi-structured interviews and focus groups
were used to identify and explore barriers to insulin initi-
ation as viewed by healthcare professionals. A qualitative
methodology was used as it allowed us to explore and
probe the beliefs, experiences and views of the healthcare
professionals concerning insulin initiation as encoun-
tered in their respective local practices [21].
For the focus group discussions, we selected and
grouped the participants based on their practice back-
ground and location to ensure homogeneity and to capital-
ise on their shared experiences [22]. The focus groups
consisted of two groups of private primary care doctors
(n=4, n=7), public family medicine specialists (n=8) and
public medical officers in a university hospital primary care
clinic (n=8). In-depth interviews were used for key opin-
ion leaders, such as government policy makers, and also
for those who were unable to commit to a focus group ses-
sion due to their busy schedule. The use of in-depth inter-
views, focus group discussions and field notes provided the
basis for the triangulation of the data. Although all inter-
views were conducted in English, some participants used
Malay-language words and phrases during the interviews
as Malay is the national language.
Setting
The study was conducted amongst healthcare profes-
sionals who provided diabetes care in the three healthcare
settings in Malaysia: the government health clinics; gov-
ernment university-based primary care clinic and hospital;
and private general practice (GP) clinics and hospitals. Key
government policy makers who were involved in shaping
the national diabetes strategic plans were also interviewed.
A spectrum of practice experience was represented. The
healthcare professionals came from three different states
and from both urban and semi-rural locations.
Participants, recruitment, sampling
Purposive sampling was used whereby we identified stake-
holders who were involved in insulin initiation in both pri-
mary and secondary care and contacted healthcare
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endocrinologists, family medicine specialists, government
policy makers, general practitioners, government medical
officers and diabetes nurse educators. A pattern of snow-
ball sampling developed as the participants named indivi-
duals and organizations who were involved in diabetes
care particularly healthcare professionals who initiated in-
sulin therapy. Sample size was determined by data satur-
ation whereby interviews were stopped when no new
themes emerged from the interviews.
Data collection
An interview topic guide was developed based on litera-
ture review, clinical knowledge and research experience
(Table 1). The same guide was used for both individual
and focus group discussions. Participants consented to
be audio-recorded and interviews were carried out by ei-
ther one of two researchers who were trained to conduct
qualitative interviews and facilitate focus groups. Care
was taken to avoid potential participant response bias by
avoiding, whenever possible, having participants inter-
viewed by close acquaintances, lecturers or colleagues.
An assistant took detailed notes and observed non-verbal
cues during the interviews and these observations acted
as field notes. Between October 2010 and May 2011, we
conducted ten 30–40 min individual interviews and four
one hour-long focus groups. We stopped data collection
when data saturation was reached for both interviews
and focus groups. The interviews and focus groups were
audio-recorded and transcribed verbatim. The transcripts
were checked for accuracy and used as data for analysis.
Data analysis
A hermeneutic-phenomenological approach was employed
when analysing the data, which was viewed as being both
descriptive and interpretive [23]. The interpretive focus of
hermeneutics occurred from the ‘outside’ ,w h e r e b yt w oo f
the researchers’ backgrounds as clinicians influenced how
they not only interpreted the data but also how their inter-
actions with the participants during interviews were influ-
ential in constructing the text. The hermeneutic perspective
was also acknowledged on the ‘inside’, from the perspec-
tive of the participants, whereby data was viewed as con-
sisting of how participants interpreted barriers to insulin
initiation, both from their perspective as healthcare pro-
viders, and also on behalf of their patients [24]. The
researchers familiarised themselves with the data by
reading and re-reading the transcripts. Three researchers
coded two transcripts (interviews with a primary care
physician and a government policy maker) independently
and created a list of nodes (themes). Subsequently, the
researchers used this framework to code (label) the two
other transcripts individually. The coding was then com-
pared for inter-rater consistency and any coding discrep-
ancies were resolved by discussion until consensus was
reached on the list of nodes and the coding descriptions.
The finalised list of nodes and coded transcripts were
imported into Nvivo9 software which formed the basis
for future coding.
The remaining transcripts were distributed among the
three researchers (YKL, PYL, CJN) and coded individu-
ally. Any new nodes emerging during coding were added
to the list upon consultation with the other researchers.
The list of nodes was regrouped into larger categories as
a pattern of themes emerged from the data.
Two of the researchers (CJN, PYL) are family medicine
specialists and the third is a postgraduate psychologist (YKL)
and thus data analysis was from both clinical and non-
clinical perspectives. The researchers constantly reflected
and debated on the potential biases which they might carry
with them due to their backgrounds to improve credibility
of the analysis.
Ethics approval
This study received ethics approval from the Medical
Research and Ethics Committee, Ministry of Health,
Malaysia.
Results
A total of 38 healthcare professionals participated in the
study. Besides individual interviews, two focus group dis-
cussions were conducted with general practitioners in
private practice (n=7; n=4), one focus group with fam-
ily medicine specialists from public health clinics (n=9),
and another focus group (n=8) with medical officers
from a public hospital-based primary care clinic. Partici-
pants’ demographic data are shown in Table 2.
Three main categories of barriers emerged from the
analysis and are reported below: patient barriers, health-
care professional barriers and system barriers (Table 3).
Quotations are verbatim whereby colloquialisms and
Malay-language words (with translations), if any, are not
Table 1 Barriers to insulin initiation interview/focus
group topic guide
 Is starting insulin a difficult decision for your patients?
 How do they feel when making this decision?
 What are the things that patients consider before they decide
whether or not to start insulin?
o Information
o Values
o Influence from others
 What barriers do you face when advising them to start insulin?
 What kind of help do you need to overcome these barriers?
 What barriers do you face when shaping policies on
insulin treatment? (additional question for policy makers)
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multi-lingual setting.
Patient barriers
The participants highlighted a range of barriers faced by
patients when starting insulin. The list includes fears
associated with insulin; patients’ perceptions of insulin;
lack of knowledge and self-efficacy.
Fear of side effects and pain
The healthcare professionals found that patients’ fear of
side effects, such as hypoglycaemia and weight gain, were
common barriers faced by patients.
“(Patients are) afraid of hypo. Because they have seen
people with hypo, it’s so bad. They lost consciousness
and they talk nonsense and all that.”
Family medicine specialist, public health centre
“The youngsters especially...they are very worried
about weight gain.”
Medical officer, public university primary care clinic
Other emotional factors that influenced patients’ deci-
sion on starting insulin included patients’ fear of needles
and pain.
“All of us are brought up (to believe that) injection is
pain. So a lot of them have a (pause) idea that it is
associated with pain”
Diabetes nurse educator, public university hospital
“The moment we say injection, for them, injection is
the long needle...the big needle. So that’s the idea...”
Medical officer, public university primary care clinic
Misconceptions about insulin
Insulin is lethal. The healthcare professionals cited that
patients’ perceived insulin as a drug with ‘lethal’ compli-
cations. Patients believed that they would die soon after
initiating insulin because they observed that the disease
deteriorated in other patients soon after insulin initi-
ation. As a result, they perceive that insulin is the cause
of severe diabetic complications.
“It’s..it’sa ...especially among the elderly patients,
they'll be told that when they reach the stage where
they need insulin, err...that's one foot in the grave
already”
Table 2 Demographic profile of participants
Characteristics Number
(n=38)
% Mean±SD (Range)
Age 47.0±9.9 years
(30–66 years)
Sex
Female 29 76.3
Male 9 23.7
Ethnicity
Malays 13 34.2
Chinese 12 31.6
Indians 10 26.3
Others 3 7.9
Professional background
General practitioner 11 36.7
Family medicine specialist 10 33.3
Government policy maker 4 13.3
Diabetes nurse educators 3 10.0
Endocrinologists 2 6.7
Healthcare sector
Public 24 63.2
Private 14 36.8
Table 3 Barriers to insulin initiation faced by Malaysian
healthcare professionals
Patient barriers
 Fear of side effects and pain
 Misconceptions about insulin
o Insulin is lethal
o Insulin is a punishment
o Insulin is a stigma
o Insulin is a medication for old people
o Insulin causes sexual dysfunction
o Insulin is unlawful for Muslims
 Seeking alternative treatment
 Lack of knowledge and self efficacy
 Negative influence from family members
Healthcare professional barriers
 Negative attitudes towards insulin
 Lack of motivation and confidence
 Training-related barriers
 Conflicting advice from the healthcare professionals
System barriers
 Lack of continuity of care
 Lack of manpower
 Lack of resources
 Language barriers
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“...so they (patients) feel that the moment they put
insulin, after a few years is kidney damage, then dialysis.
So they have that fear, every time they’ll ask us, “Doctor
if I use insulin, will my kidneys get damaged?””
General practitioner, private practice
Insulin is a punishment. Some patients perceived insu-
lin as a ‘punishment’ to them. The healthcare profes-
sionals believed that this could be due to doctors
framing insulin as a penalty for failing to control their
disease. A doctor quoted a patient as saying “...one doc-
tor very garang (‘fierce’), you know, scolded me because
my sugar is like this. And said if it’s not okay, I’ll start
you on insulin. So for (me) it’s a punishment”.
Insulin is a stigma. According to the healthcare profes-
sionals, using insulin might be perceived by some
patients as a stigma as they associated needles with drug
abuse. One endocrinologist observed that,
“I’ve no idea why they think they will be addicted to
insulin...I don’t know what it is about insulin perhaps
it’s the fact there’s a needle and I don’t know whether
they think it’s dadah (drugs) or what, but very often
like,‘Oh does it mean sampai mati saya kena ambil (I
have to take insulin until I die) or umm...does it
mean I can’t come off it, imply that I
addicted...dependent on it...’”.
Patients also worried about having to inject insulin
during social functions where they would be surrounded
by other people.
“How to inject in front of public, like I go for dinner, I’m
going to attend a dinner with everybody on the round
table. So when can I inject myself...am I going to inject
myself in public...or where can I go myself injection?”
Medical officer, public university primary care clinic
Insulin is a medication for old people. Younger patients
viewed diabetes as an ‘old people’s disease’ and consid-
ered insulin as only needed for the elderly.
“They (young people) got a stigma...Because you see,
insulin, and diabetes, is old peoples’ disease.”
General practitioner, private practice
Insulin causes sexual dysfunction. Insulin was also
associated with men’s sexual dysfunction.
“They think by taking this tablet (diabetes medication),
it makes them, you know...ED (erectile dysfunction),
so no injection, any medicine, or any injection”
General practitioner, private practice
Insulin is unlawful for Muslims. Muslim patients were
concerned over the origin of insulin as many still
believed that it was a porcine derivative, which is unlaw-
ful under Islamic religious law.
“I think they were thinking that the insulin is from,
what do you call this, non-halal (‘lawful’)...
ah...products”
Family medicine specialist, public health centre
Inconvenience in starting insulin
Patients also perceived insulin therapy as inconvenient
and interfering with their lifestyle.
“Yeah, I think some of them said inconvenience
because they said uh especially those already retired,
they actually want to go into you know, different-
different places, different child each month, or go to the
relatives’ house and all that. So, yeah to bring, they
thought that they actually have to keep that in the
fridge all the time. So, it’s actually inconvenient for
them. Also for injection lah. I mean, if they’re actually
go out, injections probably a problems for them.”
Family medicine specialist, public health centre
Seeking alternative treatment
Complementary and traditional medications for diabetes
were also preferred for diabetes control.
“And when you tell them, your diabetes has come to a
stage where you need, er, injections, they will say they
have uh...these herbs and so on. They want to try out
herbs first.”
General practitioner, private practice
Lack of knowledge and self efficacy
Patients with diabetes often considered starting insulin
therapy as a complex task and this caused patients to
delay insulin therapy. Patients felt overwhelmed by the
instructions and were not confident to handle injections.
“...let’s talk about older people, for the older people,
they always know insulin is more complicated rather
than just following medicine. So they always say that I
cannot handle it, so I don’t want it.”
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Patients’ lack of self-efficacy stemmed from worries
about following the insulin regimen in novel situations
such as during festive meals, which are a common occur-
rence in Malaysian culture.
“...there is a lack of self-efficacy...Now self-efficacy is
mainly can you handle in a s-situation, in a situation
that you are in. And is not just what you can do, can
you handle it? Even if you know how to give yourself
injection, if you have to go for some s-social function.
What do you do? What do you do?”
Diabetes nurse educator, private practice
Being elderly, relying on others for care, suffering
from visual impairment and having irregular meal-
times also caused patients to hesitate over starting
insulin.
“For my patient, like elderly, we have resistant to start
insulin because cannot read the pen- too small and
then blur.... So, because cannot see, cannot read...they
got the eye problem”
Family medicine specialist, public health centre
The healthcare professionals felt that some patients
lacked knowledge and were reluctant to start insulin, es-
pecially those who had a short history of diabetes. Some
were not aware of the natural progression of diabetes
and the need for insulin eventually.
“In fact probably they’re already diabetes for many
years but just diagnosed for two years. So they thought,
you know, it’s...it’s just too early. It’s just too early for
them to actually go for insulin.”
Family medicine specialist, public health centre
Negative influence from family members
Another barrier noticed by the health care professional is
some patients with diabetes were facing negative influ-
ence and poor support from family members especially
from their spouse to initiate insulin.
“(Patient) agreed to have insulin...Next day he came
back and said “My wife doesn't want me to...start
insulin”...My personal feeling is that he’s completely
under her thumbs, and she has decided “My husband
doesn’t need insulin”.
Endocrinologist, private hospital
Healthcare professional barriers
Healthcare professional barriers to initiating insulin ther-
apy comprised psychological barriers such as negative
attitudes towards insulin therapy, lack of motivation and
confidence. Unfamiliarity with starting insulin therapy
was also highlighted.
Negative attitudes towards insulin
Some healthcare professionals felt that it was unlikely for
patients to change their negative attitudes towards insu-
lin and to modify their lifestyle to suit the insulin regi-
men. These healthcare professionals were unwilling to
take time to teach patients about insulin therapy, and
viewed insulin as a hassle.
“I also discuss (insulin) with, um...the FMS (Family
medicine specialists) or in Terengganu and the
physicians...and a matter of factly it’s...it’s as if they
just accept the fact (that patients won’t start insulin).
“It’s difficult here! The patient doesn’t want to do, what
can we do...Patient don’t want insulin, so what can
we do?”
Government policy maker
Lack of motivation and confidence
Some doctors were not motivated to start patients on in-
sulin themselves as they could refer patients to an endo-
crinologist or a diabetic nurse. Furthermore, some
doctors still subscribed to the old school of thought that
insulin could only be initiated in a hospital setting and
not in clinics.
“I don’t push...I don’t push, because I let the
specialists handle it. Yeah, I refer them to the
specialists...”
General practitioner, private practice
Besides motivation, some doctors lacked confidence in
starting a patient on insulin. Reasons included feeling un-
comfortable with needles and unfamiliarity with the vari-
ous insulin regimens and devices. Some healthcare
professionals blamed the patients for their reluctance to
accept insulin. Even those who were successful at initiating
insulin viewed the counselling process as a battle to be
won and one requiring considerable mental preparation.
“...we ourselves have got such a mental block. I mean,
as doctors it’s very easy to preach, but when it comes to
needles I think we doctors also freak out. So when we
had to inject it was like,‘Oh dear...must I do it?’”
General practitioner, private practice
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Training-related barriers include: organizational policies
that do not support staff who want further training and
the quality of the training programme.
“...even though they (sponsors) write there black and
white for the (diabetes) educator from the clinic to go
(for training)...we are not at liberty to improve
ourselves”
Diabetes nurse educator, public university hospital
“...the training in the Ministry (of Health) is very
much didactic, not so much practical.”
Government diabetes policy maker
Conflicting advice from the healthcare professionals
Conflicting information given by healthcare profes-
sionals, peers and media tended to delay patients’ deci-
sion in starting insulin.
“...the GP told him...“No, why you so silly start on
injection for? I give you medicine. Forget it, throw it all
away.” So he went back to oral medicine....and he
came back 6 months later with renal failure.”
General practitioner, private practice
Doctors in the private sector felt that the decision to
start insulin or not was out of their control as patients
could “shop with another doctor who will tell them that
they don’t need (insulin)” (Diabetes nurse educator, pri-
vate practice).
System barriers
System barriers to insulin initiation could be divided into
four main areas: lack of continuity of care, manpower,
resources and language barriers.
Lack of continuity of care
The lack of continuity of care in primary care made insu-
lin initiation and management challenging. Therefore,
patients were often unable to maintain the follow-up
which is crucial to address individual patient’s concerns
about insulin. The lack of continuity of care is particu-
larly problematic in the public sector due to high turn-
over of doctors. Patients are often not being given a
choice on who they would like to consult as they are un-
able to book to see the same practitioner at each visit.
“So, I’ve learned that it’s important to...to...to know
your patient well but the only problem with MOH
(Ministry Of Health) is that you can’t see the same
doctor......so this fact about not having the same
doctor, patients don’t like it. They don’t like it.”
Endocrinologist, public hospital
Lack of manpower
The lack of manpower was apparent especially in the
government hospitals and clinics. Despite recognising
the important role of a nurse educator in insulin coun-
selling, only a small number of diabetes nurse educators
and dieticians were trained in the government sector
and, when present, they had to handle heavy patient
loads. Although privately-sponsored diabetes nurse edu-
cators were available to help educate patients on starting
insulin in private clinics, there were very few of them.
Lack of resources
While insulin is subsidized in the public clinics and hos-
pitals, there is no financial assistance for glucometers
and test strips. This hampers insulin initiation.
“The other thing is that I think, uhh...most of our
patient do not have home blood sugar monitoring. This
is actually very difficult in starting insulin. To actually
titrate insulin, especially for BIDS (bedtime insulin
daytime sulphonylurea) regime, it’s very difficult.”
Family medicine specialist, public health centre
Education materials about insulin were not easily avail-
able and most insulin-prescribing doctors preferred to
sketch out information on blank paper. There was also a
lack of dedicated diabetes education rooms and facilities.
Counselling patients about insulin initiation was seen as
time consuming especially in government clinics with
heavy patient load.
“...the workload...500, 600 patient a day and per
doctor we are seeing umm, 70 to 100. Not a good day,
one MC (medical leave), one taking leave, 100 a day.
So I was you know, practicing there, I have to be a
regular MO (Medical Officer), so I can find it is
difficult to counsel patient in this kind of situation.
Time is definitely you know really un-under constraint”
Family medicine specialist, public health centre
Language barriers
Language issues made it difficult for healthcare profes-
sionals to communicate with patients. Some patients
from rural and agricultural estates can only speak their
native language. This poses a big communication barrier
if the healthcare professional and the patient are from
different ethnic and linguistic backgrounds.
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actually do not have enough...uh...Indian staff.”
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Discussion
This study highlights the wide range of barriers to insu-
lin initiation in Malaysia and provides an overview as to
why the use of insulin remains low. What is remarkable
is the similarity of the barriers encountered in a multi-
cultural, Asian country to barriers reported in studies
conducted in the West. A Pubmed search of qualitative
studies which focus on barriers to insulin initiation iden-
tified eight studies from North American [25,26], UK
[27-30], European [31] and South African [32] settings.
Thematic consistency is apparent between these studies
and our study, suggesting that these barriers are widely held
ideas and that the results of this study are generalisable.
Studies on psychological insulin resistance amongst
multi-ethnic populations have found that ethnicity is an
important determining factor. Studies in the west have
found that Hispanic and ethnic minorities are less willing
to start insulin therapy [19,33]. Reasons for this resist-
ance include perceived lack of access to care and lan-
guage barriers between healthcare provider and patient
[34,35]. Malaysian society consists of three main racial
groups, each with distinct cultural practices and close-
knit community structures. The healthcare professionals
cited patients’ misconceptions of insulin as a major bar-
rier. Our study identified three misperceptions that arise
out of this multicultural setting: religious barriers, use of
complementary medicines and lethal connotations about
insulin.
The majority of Malaysia’s population are Muslim, in
which the origin of food and products must comply to
strict religious standards in order to be considered lawful
(‘halal’). Healthcare professionals need to reassure
Muslim patients that modern, synthetic insulin is not
derived from a porcine source [36], which is strictly for-
bidden except under emergency situations [37]. Another
concern for Muslim patients is the use of insulin during
Ramadan, where the Muslims would be on a full-day fast
from food and drink [38]. Healthcare professionals (in-
cluding non-Muslims) must be able to advise Muslim
patients on appropriate insulin regimes during the fast-
ing month of Ramadan [39].
Patients’ preference to try out complementary therapies
before insulin usage is often overlooked by the healthcare
professionals in Malaysia. In a local study, the use of com-
plementary therapies was prevalent among people with
type 2 diabetes mellitus [40]. Half of Malaysian patients
with chronic diseases do not report their use of comple-
mentary therapy to their doctors or pharmacists [40]. This
is of concern as the use of traditional herbs has been
identified elsewhere as a barrier to insulin therapy whereby
patients were perceived to have more faith in herbs than in
insulin [32]. Increasing healthcare professional awareness
on complementary and traditional therapies will help to
reduce healthcare professionals’ anxiety in advising
patients on the use of such therapies [41]. Healthcare pro-
fessionals need to play a more active role in asking their
patients about their use of complementary therapies when
initiating insulin [42].
Patients often associate insulin usage with co-morbid-
ities. Although it has been reported elsewhere that
patients associate insulin with disease severity [25,43],
this misconception appeared to be more serious among
the Malaysian patients who consider insulin to be lethal.
Healthcare professionals should, therefore, address this
misconception by counselling patients about the natural
progression of diabetes at early stage of the illness. It
should be emphasised to patients that early initiation of
insulin helps to reduce morbidity and mortality. The
myth about the association between insulin and
advanced disease and deaths should be dispelled by pro-
viding accurate and timely information to the patients.
In this study, most system barriers are similar to those
found elsewhere, including short consultation times,
rapid staff turnover and lack of continuity of care [32].
However, further matrix analysis of the data identified
two issues which were only identified in healthcare pro-
fessionals from the public healthcare system in Malaysia.
Firstly, the lack of continuity of care is particularly prob-
lematic in the public healthcare setting due to fast turn-
over of doctors and patients not being given a choice on
who they would like to consult. Continuity of family
physician care in patients with diabetes is associated with
better quality of life [44], and lower mortality and
hospitalization in elderly patients [45]. According to Pro-
chaska’s transtheoretical model [46], insulin initiation
requires patients to move from stages of precontempla-
tion, contemplation and finally to action, with patients
often cycling back and forth between these stages [47].
Continuity of care would play an important role as health-
care professionals assess the stage of patient’s readiness to
initiate insulin and customize a follow-up plan to help
patients initiate and optimize the use of insulin [48].
The language barrier was especially pressing in rural
and semi-rural locations of the public healthcare system.
Patients with limited language proficiency have problems
with healthcare access, comprehension, adherence and
receive lower quality of care overall [49]. As a self-admi-
nistered injection, insulin requires an understanding of
injection techniques and self-titration. Thus, difficulty in
communication during patient education still poses a
substantial barrier to insulin initiation in Malaysia. Strat-
egies to overcome language barriers in practice include
employing a diverse healthcare workforce and using
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healthcare professionals to serve in diverse communi-
ties can be done by offering medical language courses
in medical schools to help familiarise students with
medical terminologies they will encounter in different
communities [51].
Both public and private healthcare professionals stated
that the lack of resources was an important barrier to in-
sulin initiation. Diabetes nurse educators are an import-
ant, but lacking resource for insulin initiation, with less
than 600 diabetes nurse educators in the country serving
a diabetes population of approximately 1.6 million [52].
The cost and lack of availability of self monitoring of
blood glucose (SMBG) contribute to patients’ reluctance
to start insulin. Although the cost of insulin is subsidized
in Malaysia, glucometers and test-strips are not. There is
evidence to suggest that the frequency of SMBG is in-
versely related to out-of-pocket expenses [53,54] and
countries with the highest relative strip-cost have the
lowest use of self-monitoring [55]. Thus, one place to
start is to look into providing patients with financial as-
sistance to acquire glucometers and test-strips for SMBG
as they are essential for monitoring the response to and
side effects of insulin therapy.
Patients perceive that their diabetes is advanced once
they are advised to start insulin therapy [19]. This per-
ception may stem from the healthcare professionals’ be-
lief that insulin could only be started once the patients
reach maximum numbers and doses of oral glucose-low-
ering drugs. Previous Malaysian CPGs recommended
that insulin should only be considered in patients with
poor glycaemic control after lifestyle modifications and
maximum oral glucose-lowering therapy [56]. In the lat-
est CPG released in 2009, the recommendation has been
changed and healthcare professionals are now advised to
start insulin early, especially for patients who have poor
glycaemic control at diagnosis. More research is needed
on the prevalence of the ‘legacy effect’ of past guidelines
and changes made from previous guidelines should be
highlighted during the training and dissemination of new
guidelines [57].
The strength of this study lies in the fact that the sam-
ple encompassed all healthcare sectors and stakeholders
who were involved in insulin initiation. We were thus
able to gain an in-depth understanding of the barriers to
insulin initiation from a wide range of perspectives. Ana-
lysis of barriers according to participant ethnicity did not
reveal significant differences in terms of themes men-
tioned as healthcare professionals treat patients from
various ethnicities and encounter a range of barriers in
patients. However, participant responses highlighted the
nature of culture-specific barriers as the examples pro-
vided were often specific to one culture, such as the
names of traditional herbs.
There are a few limitations in this study. Only partici-
pants from three states (Kuala Lumpur, Selangor and
Seremban) in Malaysia were included in this study. The
culture of patients in other states, in particular the East
coast of the peninsula and East Malaysia, might be differ-
ent and hence the patients might face different barriers
when starting insulin. This limits transferability. Future
studies should include participants from other states of
Malaysia. As sample size was determined by thematic
saturation, the sample population was too small to be
analysed according to healthcare professions. Lastly, only
healthcare professionals’ perspectives were included for
this study. However, this study forms part of a larger
study and we are embarking on a study exploring
patients’ views and perceived barriers to starting insulin.
More research is necessary to explore the patients’ per-
spectives of insulin therapy. This will help substantiate
the findings from this study and identify the needs of
patients when starting insulin.
Conclusions
Tackling the issue of insulin initiation should not happen
only at the point of decision during clinical consulta-
tions. A more comprehensive healthcare education
programme should be designed and implemented.
Patients should be informed early on about the natural
progression of diabetes and the need for insulin therapy
10–15 years after the diagnosis. At the macro level,
understanding the barriers to insulin initiation helps gov-
ernment policy makers develop effective public educa-
tional programmes; design and implement training
curriculum of healthcare professionals; and plan the
resources necessary to manage this disease. At the micro
level, the awareness of the barriers to insulin initiation
helps the healthcare professionals to explore and address
patients concerns and help them to make an informed
decision about insulin initiation.
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